1. Introduction {#s0005}
===============

The interaction between the heart and the peripheral vasculature is one of the major determinants of cardiovascular performance. The progression of myocardial systolic dysfunction in chronic heart failure (CHF) is characterized by a reduction of left ventricular end-systolic elastance (LVE) and increased arterial elastance (AE), or stiffness [@bb0005], [@bb0010]. The relationship between AE and LVE represents the ventriculo-arterial coupling that is an important determinant of net cardiac performance and cardiac energetics [@bb0015]. Ventriculo-arterial coupling is known to progressively increase in CHF due to a reduction in LVE and a raise in AE [@bb0020], [@bb0025]. The failing heart is so very linked to afterload conditions during exercise. Many studies showed a progressive alteration of large-artery function with the increasing severity of CHF [@bb0030]. Recent studies have shown that increased aortic stiffness leads to an increased afterload [@bb0035] and an impaired ventriculo-arterial coupling [@bb0040], thus reducing left ventricular systolic function and exercise capacity in patients with CHF [@bb0045], [@bb0050].

The aim of our study was to demonstrate the possible relationship between elastic properties of ascending aorta, evaluated noninvasively by echocardiography, and clinical functional capacity evaluated by cardiopulmonary test in patients with NIDC.

2. Methods {#s0010}
==========

We evaluated 55 consecutive patients affected by mild to moderate CHF due to NIDC with reduced left ventricular ejection fraction (LVEF \< 45%), admitted to Cardiology Department of Spedali Civili of Brescia, Italy. 30 patients (55%) were in NYHA class II and 25 (45%) in NYHA class III. They received standard therapy of CHF in accordance with the European Society of Cardiology guidelines for the treatment of CHF [@bb0055]. NIDC was confirmed by coronary angiography. Every patient had a diagnosis of idiopathic cardiomyopathy.

The authors stated that written informed consent was obtained from each patient and that the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki.

All the patients underwent a complete echocardiography-Doppler examination (VIVID 7 echocardiograph General Electric Medical Systems, Horten, Norway). Left ventricle end-diastolic and end-systolic volumes, left ventricle end-diastolic and end-systolic diameters, ejection fraction and also left ventricular wall thicknesses at end diastole and end systole were measured in accordance with the guidelines [@bb0060]. The Doppler method was used to calculate trans-mitral early and late flow velocities (E- and A-wave components) and deceleration time. The ratio of early trans-mitral flow velocity to early mitral annular velocity (E/E′) was measured by tissue Doppler imaging [@bb0065]. LV diastolic dysfunction was classified as proposed by the Group on Diastolic Heart Failure [@bb0070]. Systolic blood pressure in pulmonary artery (sPAP) was estimated using Doppler echocardiography [@bb0075], [@bb0080].

To evaluate aortic properties of ascending aorta we assessed aortic size at four levels: Valsalva sinuses (VS), sino-tubular junction (STJ), ascending aorta (AA), and aortic arch (AAr) at the end of diastole and systole. So, aortic elastic indexes, i.e. distensibility (AoDis) and stiffness (AoStif) were calculated from the echocardiographically derived thoracic aortic diameters (indexed by body surface area --- mm/m^2^) and assessed on the basis of a two-dimensional guided M-mode recording of systolic (AoS) and diastolic (AoD) aortic diameters, 3 cm above the aortic valve. AoD was obtained at the peak of the R wave at the simultaneously recorded ECG, and AoS was measured at the maximal anterior motion of the aortic wall; five measurements were averaged for each diameter. The following indexes of aortic elasticity were calculated: AoDis = \[2 × (AoS − AoD) / AoD ∗ PP\] (mm Hg^−\ 1^); (AoStif) = ln(SBP/DBP) / \[(AoS − AoD) / AoD\] (pure number) where SBP and DBP refer to brachial systolic and diastolic BP respectively, in mm Hg and pulse pressure (PP) was calculated as SBP − DBP [@bb0085].

All the patients underwent a cardiopulmonary exercise (CPX) test (Marquette Hellige). It was used as a constant ramp protocol where work rate was increased of 10 W/min. Gas exchange was monitored during the exercise test with a spirometer and a computer metabolic analysis (Medical Graphics). Collected parameters were peak oxygen consumption (pVO~2~) expressed in ml/kg/min, anaerobic threshold (AT) expressed in ml/kg/min, the slope of the relation between minute ventilation (VE) and carbon dioxide production (VCO~2~). Peak VO~2~ was measured as the mean value during the last 30 s of exercise.

All data are given as mean ± standard deviation or number (percentage) of patients. Univariate and multivariate analyses were made to assess a correlation between pVO~2~, age, LVEF, hypertension, diabetes and aortic stiffness. Statistical significance was established at a level of p \< 0.05.

3. Results {#s0015}
==========

Patients were 46 males (83%) and 9 females (17%). Mean age was 60 ± 11 years old. All patients were affected by CHF due to NIDC with mean EF of 35.2% ± 7.7% and were treated with optimized medical CHF-therapy according to current guidelines: ACE-I or ARB (96%), beta blocker (96%), aldosterone receptor antagonist (64%) and diuretics (70%).

All the other characteristics and all the echocardiographic parameters are summarized respectively in [Tables 1](#t0005){ref-type="table"} and in [2](#t0010){ref-type="table"}.Table 1Characteristics of the study population of mild- to moderate CHF (n = 55).Age (years)60 ± 11Men/women46 (83%)/9 (17%)Body surface area (BSA) (m^2^)1,96 ± 0,2Systolic blood pressure (mm Hg)119 ± 15.2Diastolic blood pressure (mm Hg)74,9 ± 8,2Heart rate (bpm)68,4 ± 10,8Arterial hypertension8 (15%)Chronic obstructive pulmonary disease (COPD)6 (10%)Diabetes mellitus9 (18%)Smokers3 (5%)Dyslipidemia17 (30%)[^2]Table 2Main echocardiographic parameters of the study population (n = 55).End diastolic diameter (EDD) (cm)6.66 ± 0.79End systolic diameter (ESD) (cm)5.32 ± 0.95End diastolic volume (EDV) (ml)183.27 ± 82.58End systolic volume (ESV) (ml)132.73 ± 94.38End diastolic volume indexed (EDVi) (ml/m^2^)74.36 ± 49.23Left ventricular ejection fraction (LVEF) (%)35.2 ± 7.7Posterior wall thickness (PWT) (cm)0.95 ± 0.14Interventricular septum thickness (IVT) (cm)1.05 ± 0.18Left ventricular mass (LV mass) (g)Valsalva sinuses (VS) (mm)37.23 ± 6.37Sino-tubular junction (STJ) (mm)35.32 ± 2.56Ascending aorta (AA) (mm)42.93 ± 4.65Aortic arch (Aar) (mm)33.28 ± 2.96Aorta in systole (AoS) (mm)33.24 ± 5.03Aorta in diastole (AoD) (mm)34.95 ± 5.1Aortic distensibility (mm Hg^−\ 1^)2.61 ± 2.39Aortic stiffness index15.63 ± 14.53E/A ratio0.75 ± 0.20Deceleration time (DT) (msec)244.6 ± 80.4E/e′ ratio14.7 ± 6.26Pulmonary artery systolic pressure (mm Hg)30.5 ± 5.5Left atrium diameter (cm)4.63 ± 0.9Left atrium area (cm^2^)25.01 ± 7.57[^3]

Peak VO~2~ at CPX was 15.4 ± 3.9 ml/kg/min, VE/VCO~2~ ratio at AT was 36.1 ± 6.1; mean respiratory exchange ratio (RER) was 1.1 ± 0.14 thus meaning that a maximum metabolic effort was performed. All the other parameters evaluated during CPX were summarized in [Table 3](#t0015){ref-type="table"}.Table 3CPX parameters of the study population (n = 55).Peak VO~2~ (ml/kg/min)15.4 ± 3.9Peak VO~2~ (ml/min)1284.13 ± 369.2Max theoretical VO~2~ (ml/kg/min)26.45 ± 5.02Max theoretical VO~2~ percentage reached (%)58.56 ± 14.26Anaerobic Threshold (AT) (ml/kg/min)10.55 ± 3.59VE/VCO~2~ ratio at AT36.1 ± 6.1Respiratory Exchange Ratio (RER)1.1 ± 0.14Maximum workload (Watt)102.4 ± 30.59[^4]

Mean AoDis was 2,61 ± 2.39 mm Hg^−\ 1^ and mean aortic stiffness 15,63 ± 14,53.

At univariate analysis only pVO~2~ was found to be directly correlated with AoDis (r = 0.47, CI 0.25--0.66, p = 0.0002) and negatively correlated to AoStiff (r = − 0.51, CI − 0.68 to − 0.20, p = 0.0001) \[[Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}\]. The correlations were also demonstrated at multivariate analysis, corrected by hypertension, diabetes, age and ejection fraction (respectively r = 0.27, p = 0.008 and r = − 1.75, p = 0.0002). In [Table 4](#t0020){ref-type="table"} was shown the predictors of peak volume oxygen consumption.Fig. 1Correlation between aortic distensibility and pVO~2~ (dashed lines represent ± 1 standard deviation interval).Fig. 2Correlation between aortic stiffness and pVO~2~ (dashed lines represent ± 1 standard deviation interval).Table 4Predictors of peak volume oxygen consumption (VO~2~).VariablePearson\'s correlation coefficientpAge− 0.26400.0515SAP− 0.18040.1876DAP− 0.17770.1942LVEF0.16380.2322LVMI− 0.16110.2400Aortic distensibility0.470.0002Aortic stiffness index− 0.510.0001

4. Discussion {#s0020}
=============

This study demonstrates that aortic stiffness (measured non-invasively using 2D guided M-mode echocardiography) is an independent predictor of exercise capacity in patients with CHF and NIDC.

Our results are consistent with other reports that showed a correlation between elastic properties of ascending aorta and functional capacity in CHF patients using different echocardiographic methods [@bb0045], [@bb0050]. The echocardiographic method used to evaluate aortic stiffness in CHF patients is simple and easy to acquire and is not dependent on pulse wave Doppler echocardiography.

An impaired aortic compliance is frequent among CHF patients [@bb0090], [@bb0095], [@bb0100] and we showed that aortic stiffness is inversely related to peak VO~2~, which is a major predictor of mortality among CHF patients [@bb0105]. Our study cannot establish a causal relation between aortic stiffness and decreased functional capacity. Actually, the elastic proximal aorta is the main region that is affected by aging, hypertension, diabetes or LV diastolic dysfunction. Therefore an increased aortic stiffness may represent a marker of more advanced disease in CHF patients. Despite that, several pathophysiological mechanisms suggest a possible causal relation between aortic stiffness and exercise tolerance and in our population a relation between aortic stiffness and functional capacity was maintained after correction for other variables.

The elastic properties of aorta are crucial for an optimal ventriculo-arterial coupling [@bb0035], [@bb0110] and a stiffer aorta has a negative impact on cardiac function and functional capacity of CHF patients through different mechanisms. First, in a stiffer aorta the cushioning effect of its proximal tract is reduced, thus increasing LV afterload with further compromising the ability to generate an adequate cardiac output during exercise. This is particularly true in CHF patients because it is known that the function of the failing heart is very dependent on the increase of afterload. Kelly et al. have shown that a less compliant aorta may affect both LV systolic energetics and mechanics: when the aorta was experimentally stiffened, an increase in cardiac energetic cost for a given stroke volume (SV) was observed [@bb0115] and SV varied inversely with aortic stiffness [@bb0120]. The alterations of ventriculo-aortic coupling seem to further exacerbate during exercise due to increased heart rate and an earlier reflection of pulsed wave from the periphery back to the aortic root [@bb0020].

Secondly, combined ventricular--aortic stiffness could potentially reduce the cardiovascular reserve [@bb0125]. Therefore, the ability of the heart to accommodate the peripheral demands and the increased pre-load during exercise may be reduced, with an increase in left atrial pressure, and then in pulmonary capillary wedge pressure responsible of the appearance of shortness of breath eliminating the exercise capacity.

Thirdly, a stiffer aorta influences the exercise capacity by LV relaxation. The study of Patrianakos et al. shows a link between aortic stiffness and a more advanced grade of diastolic dysfunction [@bb0050]. This condition is associated with an increase of LV end-diastolic pressure at rest which increases more during exercise for an increase in heart rate and a reduction in diastolic period.

A study on a population of patients with CHF with preserved ejection fraction (HFPEF) observed that these subjects have a more stiffened aorta and this condition could determine the development of a more advanced diastolic dysfunction that consecutively could worsen the ventriculo-arterial coupling and contribute to the pathophysiology of HFPEF [@bb0130]. These data confirm the positive linkage between aortic stiffness and LV filling pressure. In these patients many comorbidities can explain the less aortic distensibility and the development of HFPEF such as elderly age [@bb0135], end-stage renal failure [@bb0140] and hypertension [@bb0145] that are known as causes of myocardial hypertrophy, the substrate at the basis of diastolic dysfunction.

There are several mechanisms that can affect aortic function. The ability of the aorta to buffer the pulsatile component of the LV afterload relies on a complex network of elastin, collagen and smooth muscle cells [@bb0150], [@bb0155]. Changes in the relative proportion of these components alter the elastic properties of aorta: an increase in collagen, which is more stiffer, and a reduction of elastin, which is easily stretched, make the arterial wall less elastic [@bb0150]. This suggests that abnormalities in extracellular matrix turnover might involve the proximal elastic vasculature and can in part explain the progressive stiffening process of large artery in CHF [@bb0155].

The enhanced activation of renin--angiotensine--aldosterone system (RAAS) in patients with CHF and dilated cardiomyopathy is probably an important cause of aortic stiffness. Aortic stiffening involves vascular smooth muscle hypertrophy, inflammation, and collagen accumulation, mechanisms which have been reported to be induced by aldosterone [@bb0160]. Activation of RAAS leads to sodium and water accumulation in arterial walls and determinates wall edema, thus increasing vascular stiffness [@bb0165]. Sodium retention also promotes extracellular matrix (ECM) synthesis and deposition and changing smooth muscle cell phenotype, which impair vascular compliance [@bb0170]. Finally, vascular inflammation, which plays an important role in the progression of CHF, might be involved in the accelerated ECM turnover that contributes to both myocardial and arterial fibrosis [@bb0175], and a significant relation between high serum C-reactive protein levels and impaired aortic compliance has been described in patients with idiopathic dilated cardiomyopathy [@bb0175]. Even in chronic inflammatory diseases like rheumatoid arthritis we have previously demonstrated a correlation between aortic stiffness and the progression of systolic and diastolic function with a possible explanation that altered ventriculo-arterial coupling could contribute to the pathophysiology of CHF [@bb0180].

There are potential limitations to the present study. First, we used a noninvasive brachial cuff pressure measurement instead of a direct assessment of the aortic pulse pressure by a catheter. It has been shown that pulse pressure may be lower using a noninvasive method; however, others have shown an excellent correlation (r = 0.95, p \< 0.001) of the calculated aortic distensibility using invasive and noninvasive methods [@bb0185]. Second, most of our patients with systolic CHF received long-term medication with agents that might improve aortic distensibility (such as spironolactone) or decrease exercise tolerance (such as beta-blockers). Third, it is possible that impaired systolic performance could directly affect aortic distensibility in patients with systolic CHF; however, it is known that stroke volume and cardiac output are usually adequate in compensated patients with systolic CHF at rest. Moreover in our population no association was found between aortic stiffness and LVEF. Fourth, since 96% of our population was treated with beta-blockers we can hypothesize that these drugs may have influenced aortic elastic properties. To our knowledge, no studies have already evaluated the effects of beta-blockers on ascending aorta distensibility and stiffness.

In conclusion this study confirms that among HF patients with NIDC aortic stiffness is correlated with peak VO~2~ and is an independent predictor of exercise capacity. These data suggest that decreased aortic distensibility may cause hemodynamic impairment. Aortic stiffness has a negative impact on cardiac function and functional capacity.
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[^1]: The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

[^2]: Data are presented as the mean value ± SD, or number (percentage) of patients.

[^3]: Data are presented as the mean value ± SD, or number (percentage) of patients.

[^4]: Data are presented as the mean value ± SD, or number (percentage) of pts.
